Comparison of Caco-2, IEC-18 and HCEC cell lines as a model for intestinal absorption of genistein, daidzein and their glycosides

Environmental Toxicology and Pharmacology

Volumn 16, Issue 3, 2004, Pages 131-139

  Steensma, Aukje ^a   Noteborn, Hub P J M ^a   Kuiper, Harry A ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Absorption; Actate dehydrogenase; ALP; Gastrointestinal; Genistein; Isoflavones; LDH; lkaline phosphatase; Metabolism; Olyethyleneglycol; PEG4000; Ransepithelial electrical resistance; Ransmission electron microscopy; TEER; TEM

Indexed keywords

DAIDZEIN; GENISTEIN; GLYCOSIDE; ISOFLAVONE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG METABOLISM; DRUG TRANSPORT; GLUCURONIDATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE ABSORPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SULFATION;

EID: 1542611527     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2003.11.008     Document Type: Article

References (51)

1. Adlercreutz H., Mazur W. Phyto-oestrogen and western diseases. Ann. Med. 29:1997;95.
2. Agullo G., Gamet L., Besson C., Demigné C., Rémésy C. Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma HT29 and Caco-2 cells. Cancer Lett. 87:1994;55.
3. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine specific protein kinases. J. Biol. Chem. 262:1987;5592.
4. Anderberg E.K., Nystrom C., Artursson P. Epithelial transport of drugs in cell culture. Part VII. Effects of pharmaceutical surfactant excipients and bile acids on transepithelail permeability in monolayers of human intestinal epithelial (Caco-2) cells. J. Pharmacol. Sci. 81:1992;879.
5. Andlauer W., Kolb J., Fürst P. Absorption and metabolism of genistin in the isolated rat small intestine. FEBS Lett. 475:2000;127.
6. Artursson P. Cell cultures as models for drug absorption across the intestinal mucosa. Crit. Rev. Ther. Drug Carrier Syst. 8:1991;305.
7. Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 22:1996;67.
8. Baily C.A., Bryla P., Malick A.W. The use of intestinal epithelial cell culture model, Caco-2, in pharmaceutical development. Adv. Drug Deliv. Rev. 22:1996;85.
9. Barnes, S., Sfakianos, J., Coward, L., Kirk, M., 1996. Soy isoflavones and Cancer prevention, underlying biochemical and pharmacological issues, In: Butrum, R. (Ed.), Dietary Phytochemicals in Cancer Prevention Treatment, Plenum Press, New York, p. 87.
10. Bessey O.A., Lowry O.H., Brock M.J. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J. Biol. Chem. 164:1946;321.
11. Bingham S.A., Atkinson C., Liggins L., Bluck L., Coward A. Phyto-oestrogens: where are we now? Brit. J. Nutrit. 79:1998;393.
12. Clarkson T.B. Soy phytoestrogens: what will be their role in postmenopausal hormone replacement. Menopause. 7:2000;71.
13. Coward L., Barnes N.C., Setchell K.D.R., Barnes S. The antitumour isoflavones, genistein and daidzein, in soybean foods of American and Asian diets. J. Agric. Food Chem. 41:1993;1666.
14. Coward L., Kirk M., Albin N., Barnes S. Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin. Chim. Acta. 247:1996;121.
15. Davies M.J., Bowey E.A., Adlercreutz H., Rowland I.A., Rumsby P.C. Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoymethane-treated rats. Carcinogenesis. 20:1999;927.
16. Day A.J., DuPont S.M., Ridley S., Rhodes M., Rhodes M.J.C., Morgan M.R.A., Williamson G. Deglycosilation of flavonoids and isoflavonoid glycosides by human small intestine and β-glucosidase. FEBS Lett. 436:1998;71.
17. Delie F., Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: Advantages amd limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst. 14:1997;221.
18. Duizer E., Penninks A.H., Stenhuis W.H., Groten J.P. Comparison of permeability characteristics of the human colonic Caco-2 and rat small intestinal IEC-18 cell lines. J. Controll. Release. 49:1997;39.
19. Duizer E., Van der Wulp C., Versantvoort C.H.M., Groten J.P. Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells. J. Pharmacol. Exp. Ther. 287:1998;395.
20. Duizer E., Gilde A.J., Vervoort C.H.M., Groten J.P. Effects of cadmium chloride on the paracellular barrier function of intestinal epithelial cell lines. Toxicol. Appl. Pharmacol. 155:1999;117.
21. Fagerholm U., Johansson M., Lennernas H. Comparison between permeability in rat and human jejunum. Parm Res. 13:1996;1336.
22. Fotsis T., Pepper M., Adlercreutz H., Fleischmann G., Hase T., Montesano R., Sweigerer L. Genistein, a dietary-derived inhibitor of In vitro angiogenesis. Proc. Natl. Acad. Sci. 90:1993;2690.
23. Gee J.M., Noteborn H.P.J.M., Polley A.C.J., Johnson I.T. Increased induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats fed diets containing purified genistein or genistein-rich soya protein. Carcinogenesis. 21:2000;2255.
24. Hashimoto K., Shimizu M. Epithelial properties of human intestinal Caco-2 cells cultured in a serum-free medium. Cytotechnology. 13:1993;175.
25. Hodgson J.M., Croft K., Puddey I.B., Mori T.A., Beilin L.J. Soybean isoflavonoids and their metabolic products inhibit In vitro lipoprotein oxidation in serum. J. Nutrit. Biochem. 7:1996;664.
26. Jacquez, J.A., 1985, Compartmental Analysis in Biology and Medicine. The University of Michigan Press, Ann Arbor, p. 510.
27. Kaufmann W.K. Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints. Proc. Social Exp. Biol. Med. 217:1998;327.
28. Lehtonen J.Y.A., Adlercreutz H., Kinnunen P.K.J. Binding of daidzein to liposomen. Biochim. Biophys. Acta. 1285:1996;91.
29. Ma T.Y., Hollander D., Bhalla D., Nguyen H., Krugliak P. IEC-18, a nontransformed small intestinal cell line for studying epithelial permeability. J. Lab. Clin. Med. 120:1991;329.
30. Macé K., Offord E.A., Harris C.C., Pfeifer A.M.A. Development of In vitro models for cellular and molecular studies in toxicology and chemoprevention. Archiv. Toxicol. Suppl. 20:1998;227.
31. Madara J.L. Regulation of the movement of solutes across tight junctions. Ann. Rev. Physiol. 60:1998;143.
32. McIntosh G.H., Regester G.O., LeLeu R.K., Royle P.J., Smithers G.W. Diary proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J. Nutrit. 125:1995;809.
33. Oitate M., Nakaki R., Koyabu N., Takanaga H., Matsuo H., Ohtani H., Sawada Y. Transcellular transport of genistein, a soybean-derived isoflavone, across human colon carcinoma cell line (Caco-2). Biopharm. Drug Disposit. 22:2001;23-29.
34. Pasternak A.S., Miller W.M. Measurements of trans-epithelial electrical resistance in perfusion: potential application for In vitro ocular toxicity testing. Biotechnol. Bioeng. 50:1996;568.
35. Piskula M.K., Yamakoshi J., Iwai Y. Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett. 447:1999;287.
36. Quaroni A., Hochman J. Development of intestinal cell culture models for drug transport and metabolism studies. Adv. Drugs Delivery Rev. 22:1996;3.
37. Rao C.V., Wang C.X., Simi B., Lubet R., Kellof G., Steele V., Reddy B.S. Enhancement of experimental colon cancer by genistein. Cancer Res. 57:1997;3717.
38. Record I.R., Broadbent J.L., King R.A., Dreosti I.E., Head R.J., Tonkin A.L. Genistein inhibits growth of B16 melanoma cells in vivo and In vitro and promotes differentiation In vitro. Int. J. Cancer. 72:1997;860.
39. Reinli K., Block G. Phytoestrogen content of foods-A compendium of literature values. Nutrit. Cancer. 26:1996;123.
40. Sesink A.L.A., O'Leary K., Hollman P.C.H. Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3- glucoside or quercetin-4′-glucoside. J. Nutrit. 131:2001;1938.
41. Setchell K.D., Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J. Nutrit. 129:1999;758S.
42. Setchell K.D., Brown N.M., Desai P., Zimmet-Nechemais L., Wolfe B.E., Brashear W.T., Kirschner A.S., Cassidy A., J E. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutrit. 131:2001;1362S.
43. Spencer J.P.E., Chowrimootoo G., Choudhury R., Debnam E.S., Srai S.K., Rice-Evans C. The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett. 458:1999;224.
44. Steensma A., Noteborn H.P.J.M., Van der Jagt R.C.M., Polman T.H.G., Mengelers M.J.B., Kuiper H.A. Bioavailability of genistein, daidzein and their glycosides in intestinal epithelial Caco-2 cells. Environ. Toxicol. Pharmacol. 7:1999;209.
45. Steensma, A., Mengelers, M.J.B., Noteborn, H.P.J.M., Kuiper, H.A., 2000. Kinetic models describing In vitro transport and metabolism of isoflavones and their glycosides in human Caco-2 cells. In: Johnson, I.T., Fenwick, G.R. (Eds.), Dietary Anticarcinogens and Antimutagens. Chemical and Biological Aspects. The Royal Society of Chemistry, Cambridge, p. 58.
46. Wacker W.E.C., Ulmer D.D., Valee B.L. Metalloenzymes and myocardial Infarction. N. Eng. J. Med. 255:1956;499.
47. Walgren R.A., Walle K., Walle T. Transport of quercetin and its glycosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol. 55:1998;1721.
48. Walgren R.A., Karnaky K.J., Lindenmayer G.E., Walle T. Efflux of dietary flavonoid quercetin 4′-β-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2a. J. Pharmacol. Exp. Ther. 294:2000a;830.
49. Walgren R.A., Lin J.-T., Kinne R.K.-H., Walle T. Cellular uptake of dietary flavonoid quercetin 4′-β-glucoside by sodium-dependent glucose transporter SGLT1. J. Pharmacol. Exp. Ther. 294:2000b;837.
50. Walle K.U., French K.L., Walgren R.A., Walle T. Transport of genistein-7-glucoside by human intestinal Caco-2 cells: potential role for MRP2. Res. Commun. Mol. Pathol. Pharmacol. 103:1999;45.
51. Wong C.-K., Keung W.M. Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 3.1.6.2). Biochem. Biophys. Res. Commun. 233:1997;579.